AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543 | +85.0% | 62,360 | +112.4% | 0.01% | +100.0% |
| Q2 2023 | $834 | +23.6% | 29,360 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $675 | -22.0% | 29,360 | -4.6% | 0.01% | -28.6% |
| Q4 2022 | $865 | -99.9% | 30,763 | -5.5% | 0.01% | 0.0% |
| Q3 2022 | $920,000 | +27.6% | 32,545 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $721,000 | -23.7% | 32,545 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $945,000 | -13.4% | 32,545 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $1,091,000 | -27.4% | 32,545 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $1,502,000 | -16.2% | 32,545 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $1,793,000 | +6.9% | 32,545 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,677,000 | – | 32,545 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |